Skip to main content
. 2023 Jan 1;19(1):331–345. doi: 10.7150/ijbs.72538

Figure 2.

Figure 2

ICB response in various cancers. A ROC analysis of BST2, TIDE, MSI. Score, TMB, CD274, CD8, IFNG, T. Clonality, B. Clonality and Merck18 in predicting the ICB response in various cancers. Abbreviations: TIDE 37, Tumor Immune Dysfunction and Exclusion; TMB, Tumor Mutational Burden; IFNG, Interferon Gamma; ICB, Immune Checkpoint Blockade